Lomaira
Obesity, Childhood
Loma Linda UniversityPhase 4 / ApprovedActive
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 89/ 100
Competitive context
8 Active assets in the Obesity, Childhood cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide University of Minnesota | Phase 4 | BB |
Inositol Azienda Ospedaliero Universitaria Maggiore della Carita | Phase 4 | BB |
Iron Ain Shams University | Phase 4 | BB |
Albuterol Ohio State University | Phase 4 | BB |
Metformin University of Alberta | Phase 3 | BB |
View all 12 →
Same molecule, other indications
Lomaira is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →